ifinatamab deruxtecan - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Equinor activates ultra-deepwater drilling with the Valaris DS-17 drillship at Raia as Brazil's natural gas supply gap draws international capital.

Equinor (EQNR) activates $9bn Raia drilling campaign in Brazil as deepwater gas race intensifies

Representative image of AI-powered contract review software in a corporate legal workflow, illustrating how Docusign’s new AI contract review assistant could help streamline agreement analysis, redlining, and contract negotiations.

Docusign (NASDAQ: DOCU) pushes deeper into legal workflow automation with AI contract review launch

Flint Development wins Spotsylvania County approval for Patriot 95 logistics facility in Thornburg, VA

Arbor Energy signs 5 GW deal with GridMarket to supply zero-emission baseload power from 2029

Read More

5 minute read

Pharma Industry News

Can ifinatamab deruxtecan redefine treatment for late-stage small cell lung cancer? Here’s what the trial shows

Discover how ifinatamab deruxtecan delivered a 48% objective response rate in pretreated ES-SCLC. Read on for trial results and next steps.

byPallavi Madhiraju

September 7, 2025

web analytics